News | Atherectomy Devices
Avinger Inc. recently announced positive two-year clinical data from the pivotal VISION study of the company’s Lumivascular technology. The VISION study was designed to evaluate the safety and effectiveness of Avinger’s Pantheris system to perform directional atherectomy while, for the first time ever, allowing physicians to use real-time intravascular imaging to aid in the removal of plaque from diseased lower extremity arteries. Data from the study, which demonstrated successful achievement of all primary and secondary safety and effectiveness endpoints, supported U.S. Food and Drug Administration (FDA) 510(k) clearance of the system in 2016.
February 03, 2017
News | Stress Test Systems
For over 20 years, stress echocardiography (SE) has been widely used to help clinicians diagnose ischemic heart disease, in which coronary arteries have narrowed, leading to restricted blood flow and damage to the heart. However, in recent years, stress echocardiography has also become an established method to assess a much wider array of complex heart conditions, such as heart failure and valvular heart disease. A new document, The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE), aims to establish guidance for how best to apply, perform and interpret SE for patients with a multitude of conditions.
February 03, 2017
News | Heart Failure
Penn Medicine announced that its heart failure team is using big data to kick-start a project that is working to improve communication across the continuum of care, and ultimately reduce readmissions for heart failure patients.
February 03, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Stem Cell Therapies
Physicians and researchers at Texas Heart Institute are recruiting patients who suffer from heart failure to participate in the first-ever clinical study of combination adult stem cell therapy in cardiovascular medicine. Adult cell therapy has been studied in patients with heart disease with an excellent safety profile, though a combination of two cell types has not yet been evaluated in cardiovascular disease.
February 03, 2017
Technology | Contrast Media
Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a label update for Definity Vial for (Perflutren Lipid Microsphere) Injectable Suspension. The update removes the contraindication statement related to use in patients with a known or suspected cardiac shunt from the U.S. Prescribing Information.
February 02, 2017
Technology
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for both the Assurity MRI pacemaker and the Tendril MRI pacing lead. Patients implanted with these low-voltage devices will have the ability to undergo full body magnetic resonance imaging (MRI) scans, if required. With the approval, the Assurity MRI pacemaker is now the world's smallest, longest-lasting wireless MRI-compatible pacemaker, according to Abbott.
February 02, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | EP Lab
Researchers have developed a technique that allows them to revive parts of human hearts in the laboratory for up to 12 hours while they search for hidden sources of irregular heartbeats.
February 01, 2017
News | Analytics Software
As the useful applications of big data in the pharmaceutical and healthcare sector become increasingly apparent, 73 percent of organizations in the industry are set to begin or increase investment in big data within the next five years, according to business intelligence provider GBI Research.
February 01, 2017
Webinar | Inventory Management
How healthy is your cath lab supply chain? Do you struggle with managing inventory across your cath lab supply chain? It ...
February 01, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Structural Heart Occluders
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer PFO Occluder. The device is designed to help reduce the risk of recurrent cryptogenic strokes in patients diagnosed with a patent foramen ovale (PFO) – a small opening between the upper chambers of the heart.
February 01, 2017
Videos | EP Mapping and Imaging Systems
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system. It was cleared by ...
February 01, 2017
Technology | EP Mapping and Imaging Systems
February 1, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CardioInsight ...
February 01, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Cardiac Diagnostics
A new national survey by Orlando Health found that most women are unaware of the age at which heart screenings should begin. The American Heart Association recommends women begin undergoing regular heart screenings at age 20, but the survey found the majority of women, 60 percent, thought screenings didn't need to begin until after age 30, at least a full decade later.
January 31, 2017
News | ECG
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement offering. The offering was significantly over-subscribed and provides HTL with a strong financial base entering into 2017. The company expects to commence the international launch of its MyoVista product in the first quarter.
January 31, 2017
News | Congenital Heart
To save the life of an 11-year-old boy, Ann & Robert H. Lurie Children’s Hospital of Chicago has become the first pediatric hospital in the United States to implant the 50cc SynCardia temporary Total Artificial Heart.
January 31, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now